Arafat, Waleed <br/><br/>
Targeted radiotherapy potentiates the cytotoxicity of a novel anti-human DR5 monoclonal antibody and the adenovirus encoding soluble TRAIL in prostate cancer.  [electronic resource] 

 -  Journal of the Egyptian National Cancer Institute  Dec 2015 
 - 205-15 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2589-0409 
<br/><br/><label>Standard No.: </label>10.1016/j.jnci.2015.08.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Disease Models, Animal<br/>Drug Resistance, Neoplasm--radiation effects<br/>Drug Synergism<br/>Gene Dosage<br/>Gene Expression Regulation, Neoplastic<br/>Genes, bcl-2<br/>Humans<br/>Male<br/>Mice<br/>Prostatic Neoplasms--genetics<br/>Radiotherapy<br/>TNF-Related Apoptosis-Inducing Ligand--genetics<br/>Transcription, Genetic<br/>Tumor Stem Cell Assay<br/>Xenograft Model Antitumor Assays<br/>bcl-2-Associated X Protein--genetics